Richard Zare Reflects On Impact Of Mars Studies, Science Board

Editor's Note: The year 1996 was a big one for Richard Zare, the Marguerite Blake Wilbur Professor of Chemistry at Stanford University. In May, he was elected chairman of the National Science Board (NSB), the governing body of the National Science Foundation. His six-year term as a committee member and two-year stint as head of the board both end in 1998. In the 10 months since his election, Zare, 57, has become known for his forward-looking, hands-on approach to science policy. In mid-August

Written byKaren Young Kreeger
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Editor's Note: The year 1996 was a big one for Richard Zare, the Marguerite Blake Wilbur Professor of Chemistry at Stanford University. In May, he was elected chairman of the National Science Board (NSB), the governing body of the National Science Foundation. His six-year term as a committee member and two-year stint as head of the board both end in 1998. In the 10 months since his election, Zare, 57, has become known for his forward-looking, hands-on approach to science policy. In mid-August of last year-three months after his election-he found himself in the glare of the media spotlight as a coauthor of the monumental paper describing the possibility of fossilized bacteria in a Martian meteorite (D.S. McKay et al., Science, 273:924-30, 1996). Zare's lab at Stanford developed the laser mass spectrometer that analyzed the polycyclic aromatic hydrocarbons-one of the four lines of possible evidence for bacterial life-found in the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies